GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF

GSK plc

Financials through fiscal 2025, year ended Dec 31, 2025

$49.46−0.05 (-0.10%)

Close on Oct 19, 2026

Dividends

GSK has not reported a dividend

No dividend per share appears in GSK's annual filings since fiscal 2015.

Where these numbers come from

Parsed from the XBRL in GSK's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-1.25 reverse split on Mar 10, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GSK.

Revenue growth4.1% · median 4.4%

Gross margin72.4% · median 71.6%

Net margin17.5% · median 6.8%

Company	Revenue	Growth
MRK	$66.57B	+4.6%
PFE	$63.70B	-0.2%
BMY	$49.19B	+3.1%
GSK	£32.67B	+4.1%
AZN	$29.01B	+16.2%
VTRS	$14.74B	+4.4%

Company

Exchange: NYSE
Industry: Pharmaceutical Preparations
Employees: 500,000
Auditor: Deloitte LLP
SEC CIK: 1131399

Advertisement
300 × 250